** Shares of Natco Pharma NATP.NS rise 3.24% to 804.80
rupees as of 11:20 a.m. IST
** Drug maker top gainer on pharma index .NIPHARM , which
is up 1.2%
** NATP retains previous profit forecast for fiscal 2024,
per the transcript of Q2 post earnings analysts' call released
late Tuesday
** Co expects minimal earnings impact from the eight U.S.
FDA observations for its Kothur plant in Hyderabad
** NATP will consider inorganic growth opportunities, co
says, citing improved cash balance
** Of the 13 analysts tracking NATP, two have "strong buy,"
four "buy,", four "hold,", two "sell" and one "strong sell"
** NATP up 44% YTD, versus 28% rise in pharma index
(Reporting by Bharath Rajeswaran)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))